| Literature DB >> 26543522 |
Nirmal A Pathare1, Sara Tejani1, Harshini Asogan1, Gaitha Al Mahruqi1, Salma Al Fakhri1, Roshna Zafarulla1, Anil V Pathare2.
Abstract
BACKGROUND: The prevalence of community-associated methicillin-resistant Staphylococcus aureus [CA-MRSA] is unknown in Oman.Entities:
Year: 2015 PMID: 26543522 PMCID: PMC4621180 DOI: 10.4084/MJHID.2015.053
Source DB: PubMed Journal: Mediterr J Hematol Infect Dis ISSN: 2035-3006 Impact factor: 2.576
Demographic characteristics for the two study cohorts.
| Male/Female | 69/120 |
| Mean age±SD, years | 25.43 ± 17.5 |
| Median Age, years | 24 |
| Range, years | 1–85 |
| Male/Female | 38/78 |
| Mean age ± SD, years | 33.23 ± 8.9 |
| Median Age, years | 30 |
| Range, years | 22–62 |
Underlying risk factors for the two cohorts of the study.
| Community Cohort [n=189] | Hospital Health Care Cohort[n=116] | ||
|---|---|---|---|
| Co-morbidities, % | |||
| Diabetes Mellitus | 5.0 | 6.5 | |
| Hypertension | 4.4 | 6.5 | |
| Ulcers | 0.6 | 0 | |
| Soft tissue infections | 4.4 | 0.8 | |
| H/O Recent exposure to Antibiotics% | Yes | 8.3 | 24.4 |
| No | 71.7 | 75.6 | |
| H/o recent exposure/Hospitalization | Yes | 1.1 | 3.3 |
| No | 98.9 | 96.7 | |
| Presence of wounds/skin lesions | Yes | 6.1 | 0.8 |
| No | 93.9 | 99.2 | |
- NS, P>0.05, Chi Square test
Prevalence of CA-MRSA and HA-MRSA isolates in the Community and Health Care staff.
| Cohorts→ | Community | Hospital Health Care | p value | |
|---|---|---|---|---|
| Nasal | N, Prevalence [%] | 34,[18] | 16,[13.8] | NS |
| 95% CI, | 12.5–23.5 | 7.5–20.06 | ||
| Cell Phone | N, Prevalence [%] | 12,[6.3] | 3,[2.6] | NS |
| 95% CI, | 5.6–6.98 | 1.7–4.54 |
CI- Confidence interval;
NS, P>0.05, Chi Square test
Figure 1aAntibiotic resistance and susceptibility pattern by the Kirby-Bauer Disc diffusion method in CA-MRSA isolated (n=46).
Figure 1bAntibiotic resistance and susceptibility pattern by the Kirby-Bauer Disc diffusion method in HA-MRSA isolated (n=19).
Antibiotic sensitivity and resistance pattern of the CA-MRSA [n=19] and HA-MRSA isolates [n=46].
| Antibiotics | NHA | CPHA | RHA | NCA | CPCA | RCA | SHA | SCA |
|---|---|---|---|---|---|---|---|---|
| 10[83] | 2[17] | 12[100] | 10[63] | 6[37] | 16[100] | 7[37] | 30[65] | |
| 7[88] | 1[12] | 8[100] | 3[60] | 2[40] | 5[100] | 11[58] | 41[89] | |
| 1[100] | 0 | 1[100] | 0 | 0 | 0 | 18[95] | 46[100] | |
| 2[100] | 0 | 2[100] | 2[50] | 1[50] | 3[100] | 17[90] | 43[94] | |
| 3[100] | 0 | 3[100] | 2[50] | 2[50] | 4[100] | 16[84] | 42[91] | |
| 0 | 0 | 0 | 0 | 0 | 0 | 19[100] | 46[100] | |
| 4[100] | 0 | 4[100] | 3[75] | 1[25] | 4[100] | 15[79] | 42[91] |
N- Nasal Swab isolates; CP- Cell phone Swab isolates;
R-Number [%] of Resistant MRSA isolates;
-S†%-Number [%] of sensitive MRSA isolates, CA- Community hospital visitors; HA- Hospital Health-care workers;
S - p<0.05, N v/s CP, Chi square test. ;
NS - p<0.05, CA v/s HA, Chi square test.†